Over 1 million RT-PCR tests for detection of COVID-19 conducted in India: ICMR

Image
Press Trust of India New Delhi
Last Updated : May 02 2020 | 10:58 PM IST

The number of RT-PCR test for detection of COVID-19 conducted in India crossed the one million mark on Saturday, ICMR officials said, as the total novel coronavirus infections rose to37,776.

An ICMR official said that 10,40,000 tests have been conducted till Saturday evening, of which 73,709 were done since 9 am on Friday.

According to the officials, testing for COVID-19 has been scaled up significantly over the last two months.

Till March 31, as many as 47,852 samples were tested while till April 30, a total of 9,02,654 samples were tested for the novel coronavirus infection, an ICMR official said.

From May 1 till evening on Saturday, total 1,37,346 tests were done.

Starting with one single laboratory, the National Institute of Virology (NIV) in Pune and having 100 laboratories in the beginning of the lockdown, theRT-PCR test facility is now available in292 government and 97 private facilities across the country, officials said.

"The ICMR has reached a per day testing level of about 70,000 and has conducted 10,40,000 tests till Saturday evening," an official said.

The RT-PCR throat/nasal swab test is the best use for diagnosis of COVID-19.

RT-PCR test detects the virus early and is the best strategy to identify and isolate the individual, the apex health research body said.

Director General of ICMR Balram Bhargava recently said that the entire scientific and medical community including the private sector too has energetically risen to the occasion.

He said that a supply chain has been created. The Centre has been working with states tirelessly to ensure required reagents are supplied to testing labs in timely and calibrated fashion, enabling diversion of reagents to hotspots as needed.

"We have also decentralized the supply chain," he had said adding, "The gold standard for COVID-19 testing remains and has remained the RT-PCR test which detects the novel coronavirus. This has been our principal strategy for testing."

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: May 02 2020 | 10:58 PM IST

Next Story